Mutual Fund Ownership
Ownership as on: Fri, 19 Apr, 2024

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.48
% of AUM2.79%

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)1.08
% of AUM2.37%

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)6.40
% of AUM2.25%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)1.23
% of AUM1.98%

ITI Value Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.08
% of AUM1.54%

FAQs about Laurus Labs share price

Laurus Labs is trading at 426.25 as on Fri Apr 19 2024 10:28:01. This is -1.26% lower as compared to its previous closing price of 431.70.

The market capitalization of Laurus Labs is 22973.42 Cr as on Fri Apr 19 2024 10:28:01.

The average broker rating on Laurus Labs is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 4 analysts have given a strong sell rating

The 52 wk high for Laurus Labs is 470.90 whereas the 52 wk low is 279.65

Laurus Labs can be analyzed on the following key metrics -

  • TTM P/E: 123.27
  • Sector P/E: 30.14
  • Dividend Yield: 0.37%
  • D/E ratio: -

Laurus Labs reported a net profit of 790.11 Cr in 2023.

Recommended For You
Trending Stocks
7,107.00+217.75(3.16%)
2,082.90+58.75(2.90%)
1,531.30+36.70(2.46%)
1,450.00-17.65 (-1.20%)
2,437.10-25.65 (-1.04%)
HomeMarketsPremiumFor youGet App